GBA mutations and Parkinson's disease in Brazil

GBA mutations and Parkinson's disease in Brazil

Saved in:

Bibliographic Details
Main Author:	Carlos R. M. Rieder
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações
Series:	Arquivos de Neuro-Psiquiatria
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2019000200071&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative study of autonomic dysfunction between Parkinson’s disease with LRRK2, PRKN, and GBA mutations
by: Bárbara Maldotti Dalla Corte, et al.
Published: (2025-08-01)

GBA1 Thr408Met mutation in a patient with Parkinson’s disease
by: Yi ZHAO, et al.
Published: (2025-06-01)

GBA mutations p.N370S and p.L444P are associated with Parkinson's disease in patients from Northern Brazil
by: Carlos Eduardo de Melo Amaral, et al.

Dual-Task Performance in GBA Parkinson’s Disease
by: Karin Srulijes, et al.
Published: (2017-01-01)

Effect of GBA Mutations on Phenotype of Parkinson’s Disease: A Study on Chinese Population and a Meta-Analysis
by: Yuan Zhang, et al.
Published: (2015-01-01)

Male sex accelerates cognitive decline in GBA1 Parkinson’s disease
by: Silvia Paola Caminiti, et al.
Published: (2025-03-01)

The Association between E326K of GBA and the Risk of Parkinson’s Disease
by: Yongpan Huang, et al.
Published: (2018-01-01)

Distinctive cognitive phenotypes in Parkinson’s disease patients with GBA mutations and without dementia: a multicentre cross-sectional retrospective study
by: Chiara Longo, et al.
Published: (2025-01-01)

Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis
by: Aymeric Lanore, et al.
Published: (2025-08-01)

Penetrance of Parkinson’s disease in GBA1 carriers depends on variant severity and polygenic background
by: Emadeldin Hassanin, et al.
Published: (2025-06-01)

Reduced expression of neurogenesis genes as biomarkers of Parkinson's disease associated with mutations in the <i>GBA</i> gene: validation of the data analysis of transcriptome study
by: A. I. Bezrukova, et al.
Published: (2022-07-01)

Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA gene
by: Marco Toffoli, et al.
Published: (2022-07-01)

Comparative analysis of methods for measuring glucocerebrosidase enzyme activity in patients with Parkinson’s disease with the GBA1 variant
by: Jin Hwangbo, et al.
Published: (2025-04-01)

Nurr1 deficiency impairs autophagy-lysosomal function through GBA-dependent transcriptional regulation in Parkinson’s disease pathogenesis
by: Cheng Cheng, et al.
Published: (2025-06-01)

CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants
by: Stefanie Lerche, et al.
Published: (2024-10-01)

Olfactory function and Parkinson's disease in Southern Brazil Função olfatória e doença de Parkinson no sul do Brasil
by: Ricardo Santin, et al.
Published: (2010-04-01)

GBA genotype-Parkinson’s phenotype correlation in a cohort of 252 Italian patients from the Tuscany region
by: Rodolfo Tonin, et al.
Published: (2025-01-01)

Is Gauchian genotyping of GBA1 variants reliable?
by: Nahid Tayebi, et al.
Published: (2025-05-01)

Reply to: Is Gauchian genotyping of GBA1 variants reliable?
by: Marco Toffoli, et al.
Published: (2025-05-01)

The most common structural variant expected at the GBA1 locus may be detected by a simple amplification method: Implications for screening Parkinson’s disease variants
by: Roberto Rozenberg, et al.
Published: (2025-01-01)

Genetics of Parkinson’s disease in Brazil: a systematic review of monogenic forms
by: Bruno L. Santos-Lobato, et al.
Published: (2021-08-01)

A novel allosteric GCase modulator prevents Tau accumulation in GBA1 WT and GBA1 L444P/L444P cellular models
by: Matteo Ciccaldo, et al.
Published: (2025-05-01)

Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort studyResearch in context
by: Thomas Hugentobler Schlickmann, et al.
Published: (2025-04-01)

Assessment of Nonverbal and Verbal Apraxia in Patients with Parkinson’s Disease
by: Monia Presotto, et al.
Published: (2015-01-01)

Prevalence and incidence of Parkinson’s disease and other forms of parkinsonism in a cohort of elderly individuals in Southern Brazil: protocol for a population-based study
by: Gabriela Magalhães Pereira, et al.
Published: (2021-12-01)

Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
by: Matteo Gastaldi, et al.
Published: (2023-10-01)

Postural instability and falls are more frequent in Parkinson’s disease patients with worse trunk mobility
by: Nathalie Ribeiro Artigas, et al.
Published: (2016-07-01)

Reliability and validity of a scale for measurement of trunk mobility in Parkinson's disease: Trunk Mobility Scale
by: Clarissa R.C. Franco, et al.
Published: (2011-08-01)

“They wanted to, but they just couldn’t get there”: GBA + implementation and gaps during the COVID-19 pandemic in Canada
by: Muhammad Haaris Tiwana, et al.
Published: (2025-05-01)

Bioenergetic consequences of PINK1 mutations in Parkinson disease.
by: Andrey Yurevich Abramov, et al.
Published: (2011-01-01)

20285. FENOTIPADO COGNITIVO DE LA ENFERMEDAD DE PARKINSON GBA: UN ESTUDIO SOBRE LOS RESULTADOS DE LA ESTIMULACIÓN CEREBRAL PROFUNDA A CORTO Y LARGO PLAZO
by: J. Fernández Vidal, et al.
Published: (2024-11-01)

Designing Primers with a Plant Signal Peptide to Enhance the Expression of GBA1 in Transgenic Soybean Plants
by: Zainab Tuama Aldahlee
Published: (2021-12-01)

Translation, linguistic and cultural adaptation, reliability and validity of the Radboud Oral Motor Inventory for Parkinson's Disease – ROMP questionnaire
by: Monia Presotto, et al.

Different outcomes of phonemic verbal fluency in Parkinson’s disease patients with subthalamic nucleus deep brain stimulation
by: Aline Juliane Romann, et al.

Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's Disease?
by: Joanne Clark, et al.
Published: (2011-01-01)

Funções executivas na Doença de Parkinson: revisão da literatura = Executive functions in Parkinson’s Disease: systematic review of literature = Funciones ejecutivas en la Enfermedad de Parkinson: revisión sistemática de la literatura
by: Macuglia, Greici Rössler, et al.
Published: (2012-01-01)

6-O-alkyl 4-methylumbelliferyl-β-D-glucosides as selective substrates for GBA1 in the discovery of glycosylated sterols
by: Stef Bannink, et al.
Published: (2024-11-01)

Mutations in the genes of lysosomal storage diseases as a risk factor for the development of Parkinson’s disease
by: A. K. Emelianov, et al.
Published: (2025-06-01)

The C. elegans gba-3 gene encodes a glucocerebrosidase that exacerbates α-synuclein-mediated impairments in deletion mutants
by: Ning Liu, et al.
Published: (2025-02-01)

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
by: Bruno Lopes SANTOS-LOBATO, et al.
Published: (2020-04-01)